Fil LTD Zai Lab LTD Transaction History

Fil LTD

$95.5 Billion
Q2 2024

A detailed history of Fil LTD transactions in Zai Lab LTD stock. As of the latest transaction made, Fil LTD holds 125,941 shares of ZLAB stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,941

Previous 125,941 -0.0%

Holding current value

$3.89 Million

Previous $2.02 Million 8.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$15.95 - $26.8 $4.28 Million - $7.2 Million	-268,528 Reduced 68.07%	125,941 $2.02 Million
Q2 2023 Aug 11, 2023	BUY	$25.3 - $39.67 $762,289 - $1.2 Million	30,130 Added 8.27%	394,469 $10.9 Million
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $1.28 Million - $2.03 Million	42,235 Added 13.11%	364,339 $12.1 Million
Q4 2022 Feb 13, 2023	BUY	$22.28 - $38.71 $6.18 Million - $10.7 Million	277,462 Added 621.53%	322,104 $9.89 Million
Q3 2022 Nov 10, 2022	SELL	$34.2 - $51.69 $20.4 Million - $30.8 Million	-595,583 Reduced 93.03%	44,642 $1.53 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $457,010 - $1.06 Million	16,457 Added 2.64%	640,225 $28.2 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $9.56 Million - $18.3 Million	-174,068 Reduced 21.82%	623,768 $39.2 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $8.45 Million - $14.4 Million	80,471 Added 11.22%	797,836 $84.1 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $84.5 Million - $122 Million	675,400 Added 1609.44%	717,365 $127 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $5.27 Million - $8 Million	41,734 Added 18066.67%	41,965 $5.6 Million
Q4 2020 Feb 08, 2021	BUY	$81.94 - $135.34 $4,834 - $7,985	59 Added 34.3%	231 $31,000
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $4,398 - $5,368	60 Added 53.57%	172 $14,000
Q2 2020 Aug 13, 2020	BUY	$48.82 - $82.53 $5,467 - $9,243	112 New	112 $9,000

Others Institutions Holding ZLAB

# of Institutions

116

Shares Held

40.8M

Call Options Held

63.1K

Put Options Held

420K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account